And research is exploring its potential benefits beyond diabetes and weight loss
This is a trial or microdosing size: a 5mg vial holds two and a half 2mg starting doses, so most people move to a larger vial once they tolerate treatment
Once reserved for people with type 2 diabetes, GLP-1 medications like Ozempic, Wegovy and Mounjaro have exploded into the mainstream, and theyre not just changing waistlines, but the way we talk about hunger, cravings and metabolism itself
Wegovy shows significant promise for weight loss, with many patients sharing successful transformations and improved confidence
If you're feeling discouraged because you're not seeing the weight loss results you expected on your GLP-1, please don't give up
Moreover, monomethylarsonic diglutathione (MADG) was a substrate of Cyt19 for further methylation to dimethylarsinic glutathione (DMAG)